These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 8871928

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expression of CD44s and CD44v6 in transitional cell carcinomas of the urinary bladder: comparison with tumour grade, proliferative activity and p53 immunoreactivity of tumour cells.
    Kuncová J, Urban M, Mandys V.
    APMIS; 2007 Nov; 115(11):1194-205. PubMed ID: 18092951
    [Abstract] [Full Text] [Related]

  • 5. CD44s and CD44v6 in diagnosis and prognosis of human bladder cancer.
    Omran OM, Ata HS.
    Ultrastruct Pathol; 2012 May; 36(3):145-52. PubMed ID: 22559040
    [Abstract] [Full Text] [Related]

  • 6. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
    Pantazopoulos D, Ioakim-Liossi A, Karakitsos P, Aroni K, Kakoliris S, Kanavaros P, Kyrkou KA.
    Anticancer Res; 1997 May; 17(1B):781-6. PubMed ID: 9066620
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
    Friedrich MG, Toma MI, Petri S, Cheng JC, Hammerer P, Erbersdobler A, Huland H.
    Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma.
    Diaz LK, Zhou X, Wright ET, Cristofanilli M, Smith T, Yang Y, Sneige N, Sahin A, Gilcrease MZ.
    Clin Cancer Res; 2005 May 01; 11(9):3309-14. PubMed ID: 15867228
    [Abstract] [Full Text] [Related]

  • 13. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN, Mirejovský T, Melinová L, Mandys V.
    Neoplasma; 2000 May 01; 47(6):400-8. PubMed ID: 11263866
    [Abstract] [Full Text] [Related]

  • 14. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK.
    Br J Cancer; 2001 Jan 01; 84(2):270-5. PubMed ID: 11161387
    [Abstract] [Full Text] [Related]

  • 15. [Expression of bcl-2 and p16 in transitional cell carcinoma of urinary bladder].
    Leng J, Zhang Y, Yao X, Wen K.
    Zhonghua Wai Ke Za Zhi; 2000 Jan 01; 38(1):40-3. PubMed ID: 11831985
    [Abstract] [Full Text] [Related]

  • 16. Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome.
    Klatte T, Seligson DB, Rao JY, Yu H, de Martino M, Garraway I, Wong SG, Belldegrun AS, Pantuck AJ.
    J Urol; 2010 Jun 01; 183(6):2403-8. PubMed ID: 20403620
    [Abstract] [Full Text] [Related]

  • 17. Expression of the CD44 glycoprotein (lymphocyte-homing receptor) in untreated human breast cancer and its relationship to prognostic markers.
    de la Torre M, Heldin P, Bergh J.
    Anticancer Res; 1995 Jun 01; 15(6B):2791-5. PubMed ID: 8669866
    [Abstract] [Full Text] [Related]

  • 18. CD44 expression in sinonasal melanomas: is loss of isoform expression associated with advanced tumour stage?
    Regauer S, Ott A, Berghold A, Beham A.
    J Pathol; 1999 Jan 01; 187(2):184-90. PubMed ID: 10365093
    [Abstract] [Full Text] [Related]

  • 19. Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer.
    Matsumoto K, Satoh T, Irie A, Ishii J, Kuwao S, Iwamura M, Baba S.
    Urology; 2008 Aug 01; 72(2):444-9. PubMed ID: 18313120
    [Abstract] [Full Text] [Related]

  • 20. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 01; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.